Acquisition Opportunity Following the recent acquisition by Eximia Research, there is increased potential to offer specialized services tailored to women’s health and ophthalmology clinical trials, aligning with Tidewater Clinical Research’s current focus areas.

Regional Expansion Located in Eastern Virginia and operating within a regional market, Tidewater Clinical Research presents opportunities for localized partnerships and service expansion in clinical trial sites and patient recruitment efforts.

Technology Integration Supporting their clinical research activities with diverse tech tools—such as Google Maps and JSON-LD—indicates openness to innovative digital solutions that could improve data management, patient engagement, or site monitoring.

Growth Potential With an estimated revenue between 10 and 25 million dollars and a small team, Tidewater Clinical Research is positioned for scalable growth, especially through strategic partnerships with vendors offering clinical trial infrastructure or recruitment solutions.

Industry Focus Specialization in women’s health and ophthalmology trials offers targeted cross-selling opportunities for firms providing medical devices, therapeutic solutions, or specialized trial management services within these niche areas.